Indeed, animal studies utilizing adenoviral constructs to induce overexpression of Stamp2 in the liver were effective to improve insulin resistance and hepatic steatosis in response to high-fat diet [24] or in diabetic mouse models [49]. The gene discussed is STEAP4; the disease is Hepatic steatosis.